TEL AVIV, Feb 21- Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis, a neuro-degenerative disease, even before it completes late-stage clinical trials. At the same time, BrainStorm will conduct a Phase 3 clinical trial for NurOwn at multiple sites in the...
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.
"Blueprint for Athletes" is a service by Quest Diagnostics that provides diagnostic insights to help committed athletes improve their performance.
As many as 6 million Americans have atrial fibrillation, the most common form of cardiac arrhythmia. It’s caused when the electrical signaling that keeps our hearts beating becomes erratic, and, in its most serious forms, can lead to stroke or heart failure.
The company says it will part ways with 155 employees, leaving a core team of only 220 workers.
Kevin Lobo, Stryker chairman & CEO, talks about some of the company's newest technology in hard tissue robotics and why reform is needed in Obamacare.
CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.
Carson Block, Muddy Waters Research founder, and Justine Bone, MedSec Holdings CEO, discuss St. Jude and their response to Muddy Water's claims saying the company's cardiac devices are vulnerable to cyber attacks.
CNBC's Susan Li reports on why St. Jude Medical is being halted from trade.
Embattled Theranos still has not taken advantage of the Cleveland Clinic's offer to test the Silicon Valley startup's new blood diagnostic technology, says Dr. Toby Cosgrove.
Dr. Toby Cosgrove, Cleveland Clinic CEO, shares his thoughts on replacing Obamacare and containing the high cost of health care.
Dr. Toby Cosgrove, Cleveland Clinic CEO talks about the threat of the Zika virus, how the CDC is handling the spread of the virus, and those most at risk ahead of this summer's Olympics.
IBM Watson Health has unveiled a new partnership with the Department of Veterans Affairs to improve access to cancer care for U.S. veterans.
Shares of Envision Healthcare Holdings dropped more than 5 percent following news of its merger with AmSurg.
Running a medical device business requires understanding of the medical technology as well as the corporate environment, Uscom CEO Rob Phillips says.
Walgreens says it will close all 40 Theranos Wellness Centers and will no longer offer any Theranos services at any of its stores.
The net worth of Theranos founder and chief executive has dwindled to zero, according to Forbes Magazine.
J&J's consumer brands and medical devices units are poised for growth following turnaround efforts, CEO Alex Gorsky says.
A London start-up has invented a do-it-yourself DNA kit consumers can use to test the "athlete gene" — and other genetic identity markers.
A huge Hewlett Packard Enterprise project hopes to use massive data sets to better craft medical treatments and medicines for patients.